Arne E. Jahn

Dresden, SN, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Beyond in silico prediction: multi-omics to identify a pathogenic deep intronic HNRNPK variant in Au-Kline syndrome.

Beyond in silico prediction: multi-omics to identify a pathogenic deep intronic HNRNPK variant in Au-Kline syndrome.

Journal: Journal of human genetics

Published: April 30, 2026

17.6% of patients in a German cohort with exocrine pancreatic cancer were diagnosed with a genetic tumor syndrome-a case for universal genetic testing?

17.6% of patients in a German cohort with exocrine pancreatic cancer were diagnosed with a genetic tumor syndrome-a case for universal genetic testing?

Journal: ESMO gastrointestinal oncology

Published: February 06, 2026

Effect of a polygenic risk score in patients with late-onset, early-onset, familial, or hereditary colorectal cancer.

Effect of a polygenic risk score in patients with late-onset, early-onset, familial, or hereditary colorectal cancer.

Journal: JNCI cancer spectrum

Published: January 07, 2026

Targeted therapy in patients with genetic tumor syndromes.

Targeted therapy in patients with genetic tumor syndromes.

Journal: Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V

Published: November 10, 2025

Mismatch repair deficiency and microsatellite instability in adrenocortical carcinoma.

Mismatch repair deficiency and microsatellite instability in adrenocortical carcinoma.

Journal: ESMO open

Published: July 22, 2025

Multi-layered molecular profiling informs the diagnosis and targeted therapy of desmoplastic small round cell tumor.

Multi-layered molecular profiling informs the diagnosis and targeted therapy of desmoplastic small round cell tumor.

Journal: Nature communications

Published: February 25, 2025

Cancer prognosis and treatment results in patients with PTEN Hamartoma Tumour Syndrome (PHTS)-a European cohort study.

Cancer prognosis and treatment results in patients with PTEN Hamartoma Tumour Syndrome (PHTS)-a European cohort study.

Journal: BJC reports

Published: February 13, 2025

Long-read genome and RNA sequencing resolve a pathogenic intronic germline LINE-1 insertion in APC.

Long-read genome and RNA sequencing resolve a pathogenic intronic germline LINE-1 insertion in APC.

Journal: NPJ genomic medicine

Published: September 17, 2024

Genomic landscape and molecularly informed therapy in thymic carcinoma and other advanced thymic epithelial tumors.

Genomic landscape and molecularly informed therapy in thymic carcinoma and other advanced thymic epithelial tumors.

Journal: Med (New York, N.Y.)

Published: September 04, 2024

Comprehensive genomic and transcriptomic analysis enables molecularly guided therapy options in peritoneal and pleural mesothelioma.

Comprehensive genomic and transcriptomic analysis enables molecularly guided therapy options in peritoneal and pleural mesothelioma.

Journal: ESMO open

Published: August 16, 2024

The risk of a second primary cancer in PTEN Hamartoma Tumor Syndrome (PHTS).

The risk of a second primary cancer in PTEN Hamartoma Tumor Syndrome (PHTS).

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: August 12, 2024

Identification of Succinate Dehydrogenase Gene Variant Carriers by Blood Biomarkers.

Identification of Succinate Dehydrogenase Gene Variant Carriers by Blood Biomarkers.

Journal: Journal of the Endocrine Society

Published: May 24, 2024

Showing 1-12 of 43

Last Updated: 09/26/2026